General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 10.20
-0.10 (-0.97%)
Aug 19, 2026, 1:20 PM CST
General Biologicals Market Cap
General Biologicals has a market cap or net worth of 757.83 million as of August 19, 2026. Its market cap has decreased by -21.39% in one year.
Market Cap
757.83M
Enterprise Value
2.57B
Revenue
260.23M
Ranking
n/a
PE Ratio
1.40
Stock Price
10.20
ChartMarket Cap Chart
Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 757.83M, an increase of 131.77%. That is a compound annual growth rate of 3.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 729.50M | -6.67% |
| Dec 31, 2025 | 781.59M | -38.66% |
| Dec 31, 2024 | 1.27B | -21.11% |
| Dec 29, 2023 | 1.62B | 0.37% |
| Dec 30, 2022 | 1.61B | -22.70% |
| Dec 30, 2021 | 2.08B | -35.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneFerm Biotechnology | 1.23B |
| InnoPharmax | 1.19B |
| Excelsior Biopharma | 1.16B |
| Prince Pharmaceutical | 1.09B |
| Winston Medical Supply | 992.68M |
| DV Biomed | 973.97M |
| Original BioMedicals | 908.94M |
| Anxo Pharmaceutical | 893.94M |